Sphera Funds Management Ltd. Portfolio Stock Holdings
According to the SEC 13F filed on August 14, 2026, Sphera Funds Management Ltd. disclosed 72 stock positions valued at approximately $698.83M as of quarter-end June 30, 2026. The largest holdings include TEVA PHARMACEUTICAL INDS LTD, MINERALYS THERAPEUTICS INC, and SYNDAX PHARMACEUTICALS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 72
- Portfolio Value
- $698.83M
Holdings by Sector
Sphera Funds Management Ltd. Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD | TEVA | Healthcare | 7.27% | 1,500,082 | +363,107 | +31.94% | $50,822,778 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 5.68% | 1,469,971 | +130,000 | +9.70% | $39,659,818 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 3.17% | 1,014,606 | +290,043 | +40.03% | $22,179,287 |
| BIOGEN INC | BIIB | Healthcare | 2.99% | 96,626 | +4,100 | +4.43% | $20,877,014 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | Healthcare | 2.81% | 588,494 | -220,839 | -27.29% | $19,649,815 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 2.69% | 328,550 | +188,650 | +134.85% | $18,799,631 |
| CYTOKINETICS INC | CYTK | Healthcare | 2.68% | 219,987 | +180,170 | +452.50% | $18,740,693 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 2.61% | 245,346 | +100 | +0.04% | $18,273,370 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 2.54% | 459,340 | +43,000 | +10.33% | $17,776,458 |
| INSMED INC | INSM | Healthcare | 1.81% | 118,800 | +118,800 | +100.00% | $12,666,456 |
| SANOFI SA | SNY | Healthcare | 1.65% | 269,515 | - | - | $11,497,510 |
| ELI LILLY & CO | LLY | Healthcare | 1.38% | 8,040 | -1,000 | -11.06% | $9,643,417 |
| MADRIGAL PHARMACEUTICALS INC | MDGL | Healthcare | 1.34% | 17,419 | +8,379 | +92.69% | $9,353,132 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 1.33% | 499,029 | -75,000 | -13.07% | $9,306,891 |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 1.29% | 356,534 | +100,332 | +39.16% | $9,020,310 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 1.28% | 240,868 | -2,707 | -1.11% | $8,962,698 |
| RHYTHM PHARMACEUTICALS INC | RYTM | Healthcare | 1.28% | 80,400 | +80,400 | +100.00% | $8,926,812 |
| ORIC PHARMACEUTICALS INC | ORIC | Healthcare | 1.17% | 752,983 | +215,355 | +40.06% | $8,154,806 |
| LAM RESEARCH CORP | LRCX | Other | 1.15% | 18,470 | +18,470 | +100.00% | $8,003,605 |
| APPLIED MATLS INC | AMAT | Technology | 1.14% | 11,040 | +11,040 | +100.00% | $7,981,920 |
| TANGO THERAPEUTICS INC | TNGX | Healthcare | 1.14% | 254,250 | -89,313 | -26.00% | $7,947,855 |
| NOVARTIS AG | NVS | Healthcare | 1.12% | 50,000 | +13,000 | +35.14% | $7,832,904 |
| ABBVIE INC | ABBV | Healthcare | 1.09% | 30,256 | - | - | $7,613,620 |
| MERCK & CO INC | MRK | Healthcare | 1.08% | 58,600 | +10,000 | +20.58% | $7,530,100 |
| JOHNSON & JOHNSON | JNJ | Healthcare | 1.05% | 28,831 | - | - | $7,322,209 |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 1.05% | 196,408 | +196,408 | +100.00% | $7,320,126 |
| NUVECTIS PHARMA INC | NVCT | Healthcare | 1.01% | 382,945 | +382,945 | +100.00% | $7,042,359 |
| PFIZER INC | PFE | Healthcare | 0.99% | 286,000 | +100,000 | +53.76% | $6,886,880 |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | Healthcare | 0.92% | 176,663 | +176,663 | +100.00% | $6,432,300 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 0.91% | 105,000 | -22,000 | -17.32% | $6,337,800 |
Showing 30 of 72 holdings in the latest reporting period.
Sphera Funds Management Ltd. Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 150,000 | $23,737,500 |
| Q2 2026 | BIIB | Biogen Inc. | CALL | 100,000 | $21,606,000 |
| Q2 2026 | CYTK | Cytokinetics, Incorporated | CALL | 100,000 | $8,519,000 |
| Q2 2026 | PRAX | Praxis Precision Medicines, Inc | CALL | 12,500 | $4,184,875 |
| Q2 2026 | TLT | iShares 20+ Year Treasury Bond | CALL | 47,000 | $4,061,740 |
| Q2 2026 | ABVX | Abivax SA | PUT | 20,000 | $2,665,200 |
| Q2 2026 | TENX | Tenax Therapeutics, Inc. | CALL | 127,600 | $1,856,580 |
| Q2 2026 | ORIC | Oric Pharmaceuticals, Inc. | CALL | 100,000 | $1,083,000 |
Showing 8 of 8 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.